TrialThe British journal of dermatology2020

AURIEL-PsO: a randomized, double-blind phase III equivalence trial to demonstrate the clinical similarity of the proposed biosimilar MSB11022 to reference adalimumab in patients with moderate-to-severe chronic plaque-type psoriasis.

J Hercogová et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.